your search results

We are announcing our participation as exhibitor in the CPHI Worldwide which will be hosted in Milan from October 8 to 10, 2024. At our stand (7B14) in Hall H7 we will feature our user-friendly oral dosage forms such as orally disintegrating granules, chewable and effervescent tablets, instant drinks, and lozenges.

This year, we will again be exhibiting at CPHI Worldwide – the leading international trade show for the pharmaceutical industry. Here we will keep you updated about our product innovations we will present at CPHI and how you can schedule a meeting to see us there in person.

Interested in our newly developed products? You can now download the 2024 version of our Product & Development Portfolio. The document presents a choice of products we currently have available for you to in-license, plus our newly developed clean and natural formulations. (Please note, download requires registration of contact details).

Pharmaceutical companies are under mounting pressure to develop more user-friendly products. Faced with fierce competition, they’re also demanding more CDMO support than ever. How does a new type of CDMO offering — one that takes on the responsibility of clinical trial sponsorship — de-risk and accelerate go-to-market? Read this Q&A with Drug Development & Delivery.

The investment will help HERMES PHARMA to meet the soaring demand for the development and manufacturing of its user-friendly dosage forms. The new equipment, increased storage and production capacities will increase operational efficiency. As a result, the company will be able to further drive future growth, while helping new and existing customers to realize theirs.

EcoVadis is one of the leading and most trusted provider of business sustainability ratings. The silver medal acknowledges HERMES PHARMA’s continued commitment to sustainable and responsible practices and was awarded on the back of a rigorous review of the company’s business operations.